114 related articles for article (PubMed ID: 35146573)
1. Tumor enhancement ratio on preoperative abdominal contrast-enhanced CT scan for predicting recurrence risk in stage II colon cancer.
Ye Y; Lu W; Deng Q; Chen Y; Han S; Dai S; Chen Z; Li J; Song Y; Wang Z; Ding K
Abdom Radiol (NY); 2022 Apr; 47(4):1265-1275. PubMed ID: 35146573
[TBL] [Abstract][Full Text] [Related]
2. Extent of enhancement on multiphase contrast-enhanced CT images is a potential prognostic factor of stage I-III colon cancer.
Wang Z; Ye Y; Hu Y; Han S; Sun L; Xu D; Ding K
Eur Radiol; 2019 Mar; 29(3):1114-1123. PubMed ID: 30255251
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.
Baik H; Lee SM; Seo SH; An MS; Kim KH; Bae KB; Oh MK; Hong KH
ANZ J Surg; 2018 Jun; 88(6):587-591. PubMed ID: 28687025
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
7. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
9. The oncological outcome after right hemicolectomy and accuracy of CT scan as a preoperative tool for staging in right sided colonic cancers.
Lim M; Hussain Z; Howe A; Storey R; Petty D; Haselden J; Sebag-Montefiore D; Alexander D
Colorectal Dis; 2013 May; 15(5):536-43. PubMed ID: 23067005
[TBL] [Abstract][Full Text] [Related]
10. α-SMA
Wang Z; Han S; Xu K; Yang Q; Wang X; Tang Y; Shao Y; Ye Y
J Gastroenterol Hepatol; 2023 Dec; 38(12):2111-2121. PubMed ID: 37787084
[TBL] [Abstract][Full Text] [Related]
11. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
12. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
[TBL] [Abstract][Full Text] [Related]
13. Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
Park HL; Yoo IR; Boo SH; Park SY; Park JK; Sung SW; Moon SW
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1021-1026. PubMed ID: 30756189
[TBL] [Abstract][Full Text] [Related]
14. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
[TBL] [Abstract][Full Text] [Related]
15. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.
Böckelman C; Engelmann BE; Kaprio T; Hansen TF; Glimelius B
Acta Oncol; 2015 Jan; 54(1):5-16. PubMed ID: 25430983
[TBL] [Abstract][Full Text] [Related]
17. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.
Giráldez MD; Lozano JJ; Cuatrecasas M; Alonso-Espinaco V; Maurel J; Mármol M; Hörndler C; Ortego J; Alonso V; Escudero P; Ramírez G; Petry C; Lasalvia L; Bohmann K; Wirtz R; Mira A; Castells A
Int J Cancer; 2013 Mar; 132(5):1090-7. PubMed ID: 22833293
[TBL] [Abstract][Full Text] [Related]
18. Predicting adenocarcinoma recurrence using computational texture models of nodule components in lung CT.
Depeursinge A; Yanagawa M; Leung AN; Rubin DL
Med Phys; 2015 Apr; 42(4):2054-63. PubMed ID: 25832095
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
20. The prognostic effect of adjuvant chemotherapy in the colon cancer patients with solitary lymph node metastasis.
Yeom SS; Lee SY; Kim CH; Kim HR; Kim YJ
Int J Colorectal Dis; 2019 Aug; 34(8):1483-1490. PubMed ID: 31292725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
